DMAA

Profile

Full Name

Drugs Made In America Acquisition Corp. Ordinary Shares

Ticker Symbol

DMAA

Exchange

NASDAQ

Sector

Financial Services

Industry

Shell Companies

Country

United States

IPO

Indexes

Not included

Website

http://dmaacorp.com

Employees

-

Key Details

Price

$10.03(0.00%)

Market cap

$336.18M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$10.03
DMAA price is $10.03

30-Day Relative Volume

0.01
DMAA 30-day relative volume is 0.01

Price Performance

Price Most recent change

0%
DMAA {parameterFullLabel} has remained unchanged on Apr 16, 2025

Price YTD change

-
DMAA price ytd change is unknown

Price 1-year change

-
DMAA price 1-year change is unknown

Price 3-year change

-
DMAA price 3-year change is unknown

Price Range

Price All-time high

$10.27
DMAA price is currently -2.34% below its historical high of $10.27

Price 3-year low

$9.95
DMAA price is currently +0.80% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$336.18M
DMAA market capitalization is $336.18 million

Market cap 3-year change

-
DMAA market capitalization 3-year change is unknown

Market cap All-time high

$337.18M
DMAA market capitalization is currently -0.30% below its historical high of $337.18 million

Market cap sector rank

42%
DMAA market capitalization is higher than 42% of companies in Financial Services sector

Shares Outstanding

Shares Outstanding 1-Year Change

-
DMAA shares outstanding 1-year change is unknown

Shares Outstanding 3-Year Change

-
DMAA shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.02
DMAA beta is 0.02

200-day SMA

$10.01
DMAA price is currently +0.20% above its 200-day simple moving average

50-day SMA

$10.01
DMAA price is currently +0.20% above its 50-day simple moving average

RSI

53.10
DMAA 14-day relative strength index is 53.10

Volume

0.01
DMAA 30-day relative volume is 0.01

ATR

$0.03
DMAA average true range is $0.03

10-day Historical Volatility

3.32%
DMAA 10-day historical volatility is 3.32%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
DMAA annual revenue value is unknown

Revenue Analysts estimate

-
DMAA annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
DMAA annual revenue 1-year change is unknown

Revenue Sector rank

-
DMAA annual revenue is unknown

EPS

EPS

-
DMAA annual earnings per share value is unknown

EPS Analysts estimate

-
DMAA annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-
DMAA annual earnings per share 1-year change is unknown

EPS Sector rank

-
DMAA annual earnings per share is unknown

Profit

Gross profit

-
DMAA annual gross profit value is unknown

Gross margin

-
DMAA annual gross profit margin value is unknown

Operating profit

-
DMAA annual operating income value is unknown

Operating margin

-
DMAA annual operating profit margin value is unknown

Net income

-
DMAA annual net profit value is unknown

Net margin

-
DMAA annual net profit margin value is unknown

Expenses

Total expenses

-
DMAA annual total expenses value is unknown

Operating expenses

-
DMAA annual total operating expenses value is unknown

Cost of goods sold

-
DMAA annual cost of goods sold value is unknown

Selling, general & administrative expenses

-
DMAA annual SGA value is unknown

Depreciation and amortization

-
DMAA annual depreciation & amortization value is unknown

Interest expense

-
DMAA annual interest expense value is unknown

Income tax

-
DMAA annual income tax value is unknown

EBIT & EBITDA

EBIT

-
DMAA annual earnings before interest & taxes value is unknown

EBITDA

-
DMAA annual EBITDA value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$550.80K
DMAA annual total assets is $550.80 thousand

Non current assets

$545.80K
DMAA annual long term assets is $545.80 thousand

Current assets

$5000.00
DMAA annual total current assets is $5000.00

Cash and cash equivalents

$1400.00
DMAA annual cash & cash equivalents is $1400.00

Accounts receivable

-
DMAA annual accounts receivable value is unknown

Inventory

-
DMAA annual inventory value is unknown

Liabilities

Total liabilities

$795.70K
DMAA annual total liabilities is $795.70 thousand

Long term liabilities

$0.00
DMAA annual total long term liabilities is $0.00

Current liabilities

$795.70K
DMAA annual total current liabilities is $795.70 thousand

Accounts payable

-
DMAA annual accounts payable value is unknown

Debt

Total debt

$662.30K
DMAA annual total debt is $662.30 thousand

Total debt 1-year change

0%
DMAA {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
DMAA annual long term debt value is unknown

Short term debt

$662.30K
DMAA annual short term debt is $662.30 thousand

Equity & Capital

Shareholders equity

-$244.80K
DMAA annual stockholders equity is -$244.80 thousand

Book value

-$244.80K
DMAA annual book value is -$244.80 thousand

Retained earnings

-$279.80K
DMAA annual retained earnings is -$279.80 thousand

Working capital

-$790.70K
DMAA annual working capital is -$790.70 thousand

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-
DMAA annual cash flow from operations value is unknown

Cash from operations 1-year change

-
DMAA annual cash flow from operations 1-year change is unknown

Cash from investing

-
DMAA annual cash flow from investing activities value is unknown

Cash from investing 1-year change

-
DMAA annual cash flow from investing activities 1-year change is unknown

Cash from financing

-
DMAA annual cash flow from financing activities value is unknown

Cash from financing 1-year change

-
DMAA annual cash flow from financing activities 1-year change is unknown

CAPEX

CAPEX

-
DMAA annual capital expenditures value is unknown

CAPEX 1-year change

-
DMAA annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-
DMAA annual free cash flow value is unknown

Free cash flow 1-year change

-
DMAA annual free cash flow 1-year change is unknown

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
DMAA annual gross profit margin value is unknown

Operating margin

-
DMAA annual operating profit margin value is unknown

Net margin

-
DMAA annual net profit margin value is unknown

ROA & ROE

ROA

-
DMAA annual return on assets value is unknown

ROE

-
DMAA annual return on equity value is unknown

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
DMAA price to earnings ratio value is unknown

PE ratio Sector rank

-
DMAA price to earnings ratio is unknown

PB Ratio

PB ratio

-2038.67
DMAA price to book ratio is -2038.67

PB ratio Sector rank

0.23%
DMAA price to book ratio is higher than 0.23% of companies in Financial Services sector

PS Ratio

PS ratio

-
DMAA price to sales ratio value is unknown

PS ratio Sector rank

-
DMAA price to sales ratio is unknown

Enterprise value

Enterprise value

$336.73M
DMAA enterprise value is $336.73 million

Enterprise value Sector rank

39.95%
DMAA enterprise value is higher than 39.95% of companies in Financial Services sector

EV/EBITDA

EV/EBITDA

-
DMAA EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
DMAA EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.01
DMAA annual current ratio is 0.01

Quick ratio

-
DMAA annual quick ratio value is unknown

Leverage

Debt to equity

-2.71
DMAA annual debt to equity ratio is -2.71

Interest coverage ratio

-
DMAA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
DMAA piotroski f-score value is unknown

Altman Z-Score

-
DMAA altman z-score value is unknown

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

RRBI logo
Red River Bancshares (RRBI)
FRBA logo
First Bank (FRBA)
BSVN logo
Bank7 (BSVN)
GIG logo
GigCapital7 (GIG)
MSBI logo
Midland States Bancorp (MSBI)
RWAY logo
Runway Growth Finance (RWAY)
CARE logo
Carter Bankshares (CARE)
USCB logo
USCB Financial Holdings (USCB)
SCM logo
Stellus Capital Investment (SCM)
  • What is the ticker symbol for Drugs Made In America Acquisition Corp?
  • Does Drugs Made In America Acquisition Corp pay dividends?
  • What sector is Drugs Made In America Acquisition Corp in?
  • What industry is Drugs Made In America Acquisition Corp in?
  • What country is Drugs Made In America Acquisition Corp based in?
  • Is Drugs Made In America Acquisition Corp in the S&P 500?
  • Is Drugs Made In America Acquisition Corp in the NASDAQ 100?
  • Is Drugs Made In America Acquisition Corp in the Dow Jones?
  • When does Drugs Made In America Acquisition Corp report earnings?

What is the ticker symbol for Drugs Made In America Acquisition Corp?

The ticker symbol for Drugs Made In America Acquisition Corp is NASDAQ:DMAA

Does Drugs Made In America Acquisition Corp pay dividends?

No, Drugs Made In America Acquisition Corp does not pay dividends

What sector is Drugs Made In America Acquisition Corp in?

Drugs Made In America Acquisition Corp is in the Financial Services sector

What industry is Drugs Made In America Acquisition Corp in?

Drugs Made In America Acquisition Corp is in the Shell Companies industry

What country is Drugs Made In America Acquisition Corp based in?

Drugs Made In America Acquisition Corp is headquartered in United States

Is Drugs Made In America Acquisition Corp in the S&P 500?

No, Drugs Made In America Acquisition Corp is not included in the S&P 500 index

Is Drugs Made In America Acquisition Corp in the NASDAQ 100?

No, Drugs Made In America Acquisition Corp is not included in the NASDAQ 100 index

Is Drugs Made In America Acquisition Corp in the Dow Jones?

No, Drugs Made In America Acquisition Corp is not included in the Dow Jones index

When does Drugs Made In America Acquisition Corp report earnings?

The next expected earnings date for Drugs Made In America Acquisition Corp is May 30, 2025
On this page